Kromek Group (KMK) H2 2026 Pre-Recorded earnings summary

Executive summary

• Fiscal 2026 revenue reached GBP 27.1 million, in line with market expectations, driven by strong growth in both advanced imaging and CBRN detection segments.

• Underlying business growth was 36% year-over-year, supporting continued expansion into fiscal 2027.

• Profit before tax was GBP 2.5 million, exceeding market expectations.

• The business is positioned for further growth, with a robust pipeline and confidence in delivering on future guidance.

Financial highlights

• Revenue of GBP 27.1 million, with advanced imaging and CBRN detection both contributing to growth.

• Underlying margins maintained despite a reduction in gross margin due to lower enablement contract revenue.

• Profit before tax at GBP 2.5 million; adjusted EPS at 0.4, down from 0.5 last year due to reduced enablement revenue.

• Net debt at year-end was GBP 1.5 million, with an additional GBP 1 million cash received post year-end.

• Cash generated from operations exceeded GBP 3 million; net cash from financing was GBP 4.5 million.

Outlook and guidance

• Confident in delivering results in line with market expectations for fiscal 2027.

• Expecting margins to return to mid-50s (excluding enablement revenue) as product mix normalizes.

• Anticipate continued growth in both advanced imaging and CBRN detection segments.

• Biosecurity segment expected to enter commercial phase, with consumable-driven revenue model.